Endocrinology and diabetes
Type 1 and 2 diabetes, obesity and GLP-1, thyroid, osteoporosis, adrenal and pituitary, lipids and reproductive endocrinology.
Published issues
- Monthly endocrinology and diabetes bulletin — November 10, 2026
This issue covers what was published, presented or approved between October 11 and November 10, 2026. The month was shaped by the American Heart Association Scientific Sessions (Chicago, November 6-9), with several…
🎧 ListenAudio newscast · 6:22 min - What's next in endocrinology — October 20, 2026
This edition covers four pending regulatory decisions between now and the end of December 2026: relacorilant in Cushing's syndrome and CagriSema in obesity, in the United States, and oral orforglipron and navepegritide…
🎧 ListenAudio newscast · 4:57 min - Endocrinology and diabetes bulletin — October 10, 2026
This issue covers what was published, presented or approved between September 28 and October 10, 2026. It was dominated by the second half of the EASD meeting in Milan, with four simultaneous publications in NEJM, The…
🎧 ListenAudio newscast · 6:07 min - Monthly endocrinology bulletin — September 29, 2026
Colleagues: this edition covers what was published, presented or approved between August 30 and September 29, 2026. It was a heavy month for diabetes (three FDA decisions, an ADA/EASD consensus and the opening of the…
🎧 ListenAudio newscast · 6:05 min